CCM
CLVS

Catapult Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Catapult Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.53M Buy
27,500
+2,500
+10% +$216K 0.96% 27
2015
Q2 		$2.2M Buy
+25,000
New +$2.14M 0.32% 112

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Catapult Capital Management's CLVS Position: Q3 2015 in Review

Catapult Capital Management increased its Clovis Oncology, Inc. (CLVS) stake by 10% in Q3 2015, buying an estimated $216K and bringing the position to 27,500 shares worth $2.53M. The position accounts for 0.96% of the portfolio, ranked #27.

Catapult Capital Management first reported a position in CLVS in Q2 2015 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

  • Catapult Capital Management held 27,500 shares of Clovis Oncology, Inc. worth $2.53M as of Q3 2015.
  • Catapult Capital Management bought 2,500 Clovis Oncology, Inc. shares in Q3 2015, an estimated $216K.
  • Clovis Oncology, Inc. made up 0.96% of Catapult Capital Management's portfolio in Q3 2015, its #27 holding.
  • Catapult Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2015 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.